Where does Calyan Technologies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Calyan Technologies, Inc. ranks #15,169 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Calyan Technologies, Inc. hold?

Calyan Technologies, Inc. holds 19 US utility patents granted between 2021 and 2025, spanning 3 technology areas.

What is Calyan Technologies, Inc.'s Innovation Score?

Calyan Technologies, Inc. has an Innovation Score of 49.9 out of 100 (top 14% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Calyan Technologies, Inc. focus on?

Calyan Technologies, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 7 patents, ranking #515 of 1,943 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Calyan Technologies, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Calyan Technologies, Inc..

What does claim depth mean for Calyan Technologies, Inc.'s patents?

Calyan Technologies, Inc.'s patents average 22.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Calyan Technologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Calyan Technologies, Inc.

USPTO PatentsView assignee record - 19 granted patents across 3 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Calyan ranks #15,169 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 3 technology areas.

#15,169
of 49,997 US assignees by volume: Top 14%
by Innovation Score (49.9/100): 22.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R15169 · US Corporation #15,169 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 19 grants
MID-PACK #15,169/49,997
PHOTO-FINISH CardioFocus
CPC-NARROW A61N · 3 areas
INNOV-PAR 49.9/100
CLAIMS-DENSE 22.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: CardioFocus, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Calyan’s 49.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (21%) Velocity 20.0 pts (40%) Breadth 6.1 pts (12%) Claim depth 13.5 pts (27%)

Qualcomm Incorporated · highest

85
ABB S P A · near

50
Lindal France SAS · near

50
Calyan · this assignee

50
Elkem Silicones… · near

50
Radian Memory… · near

50
3D Lighting… · lowest

7

What this shows Calyan's Innovation Score is 49.9/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Calyan?

Each dot is one of Calyan’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Calyan’s own 22.4 claims/patent is ABOVE the 17.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Calyan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Calyan's grants concentrate

Calyan Technologies, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 36.8% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2024 (12 grants) versus a trough of 1 in 2023. By volume, Calyan sits between CSIdentity Corporation and Celgene International II Sàrl.

Calyan's three-year grant acceleration

Calyan Technologies, Inc. shows 15 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Csidentity

19
Curonix

19
Custom Wheel House

19
Cyberswitching Pa…

19
Cardiofocus

19
Carol Cole

19
Catabasis Pharmac…

19
Celgene Internati…

19
Calyan ◀

19

What this shows Calyan holds 19 patents at rank #15,194, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Calyan

By rank, the assignees closest to #15,194 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Calyan's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Calyan, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Calyan ranks #515 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (50 here).

Elkem Silicones France SAS 50 Radian Memory Systems, Illc 50 Lindal France SAS 50 ABB S.P.A. 50

Calyan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Calyan Technologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	10.5%
2022	2	10.5%
2023	1	5.3%
2024	12	63.2%
2025partial year	2	10.5%

Which technologies does Calyan Technologies, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 7

A61B - DIAGNOSIS; SURGERY; Identification 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Calyan Technologies, Inc.'s patent record in context - here's where to go next.

Calyan Technologies, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 36.8% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #15,169 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Calyan Technologies, Inc. against CSIdentity Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.